Great post WaynesWorld as always, it's also greatly appreciated...

Great post WaynesWorld as always, it's also greatly appreciated that you have found other ways to implement your contribution while the chairmans updates seem to have stalled temporarily which is where you would always appear with a great summary of that update.

I also think looking back on a recent post of SoT's where he highlighted his thoughts that it would have a far larger impact on market & sp. overall if 2 deals where reached & released in fast succession ie. days or weeks apart, i guess to maintain momentum & send a clear message that business is infact booming.

Personal opinion & by no means guaranteed that it will play out that way - but i have been thinking for a while that the best combination for a significant re-rating would be the next big pharma deal to be reached in close succesion with either Roche or Mediimune/AZ taking their partnerships to the next stage. This would not only highlight PYC's ability to form partnerships with big pharma but also validate & show that it is delivering against the targets that it has been given. Progressing to the next stage is what will clearly show market that these HUGE milestones attached to new partnerships are not just big numbers of possible outcomes but also big numbers that are certainly within reach.

Interesting times ahead